The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review

被引:50
作者
Almukhtar, Rawaa M. [1 ,2 ,3 ]
Fabi, Sabrina G. [1 ,2 ,3 ]
机构
[1] Louisiana State Univ, Dept Dermatol, 1542 Tulane Ave,Suite 639, New Orleans, LA 70112 USA
[2] Goldman Butterwick Groff Fabi & Wu Cosmet Laser D, San Diego, CA USA
[3] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA
关键词
TOXIN TYPE-A; BOTULINUM-TOXIN; TEMPOROMANDIBULAR-JOINT; SLEEP BRUXISM; BITE FORCE; HYPERTROPHY; INJECTION; MANAGEMENT; DISORDERS; ASYMMETRY;
D O I
10.1097/PRS.0000000000005083
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Masseter muscle hypertrophy manifests itself as enlargement of the masseter muscle. It can be associated with a square-angled lower face, pain, dental attrition, maxillary and mandibular bone resorption, and accelerated aging process of the lower face. The objective of this study was to assess the efficacy and safety of botulinum toxin type A in contouring the masseter and its impact on quality of life and the aging process of the lower face, and its role in full face rejuvenation. Methods: A PubMed search was conducted for articles on masseter treatment with botulinum toxin type A, masseter muscle hypertrophy, and the aging process of the lower face. Key studies are reviewed and findings are summarized. Results: Botulinum toxin type A can be injected into the lower posterior aspect of the masseter muscle. Treatment decreases muscle bulk and reshapes the lower face. Furthermore, patient quality-of-life measures, including pain and symptoms of grinding and clenching, are improved. Treatment can decrease shear stress on maxillary and mandibular bones and can possibly prevent tooth loss and progressive bone resorption of the lower face. Adverse effects are minimal and short lasting. Conclusions: Botulinum toxin type A is a safe and effective treatment of masseter hypertrophy. The treatment results in improvement of functionality and cosmesis, and restoration of facial harmony.
引用
收藏
页码:39E / 48E
页数:10
相关论文
共 59 条
[1]   Consensus Recommendations on the Aesthetic Usage of Botulinum Toxin Type A in Asians [J].
Ahn, Bong Kyun ;
Kim, Youn Sung ;
Kim, Hong Jig ;
Rho, Nark Kyoung ;
Kim, Hei Sung .
DERMATOLOGIC SURGERY, 2013, 39 (12) :1843-1860
[2]   The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophy [J].
Ahn, Ki Young ;
Kim, Seong Taek .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2007, 120 (06) :1662-1666
[3]   A review of the literature on the aging adult skull and face: Implications for forensic science research and applications [J].
Albert, A. Midori ;
Ricanek, Karl, Jr. ;
Patterson, Eric .
FORENSIC SCIENCE INTERNATIONAL, 2007, 172 (01) :1-9
[4]   Sleep bruxism; an overview of an oromandibular sleep movement disorder [J].
Bader, G ;
Lavigne, G .
SLEEP MEDICINE REVIEWS, 2000, 4 (01) :27-43
[5]   Botulinum Toxin Injection for Salivary Gland Enlargement Evaluated Using Computed Tomographic Volumetry [J].
Bae, Gee Young ;
Yune, Young Min ;
Seo, Kyle ;
Hwang, Sung Il .
DERMATOLOGIC SURGERY, 2013, 39 (09) :1404-1407
[6]   The Risorius Muscle: Anatomic Considerations With Reference to Botulinum Neurotoxin Injection for Masseteric Hypertrophy [J].
Bae, Jung-Hee ;
Choi, Da-Yae ;
Lee, Jae-Gi ;
Seo, Kyle K. ;
Tansatit, Tanvaa ;
Kim, Hee-Jin .
DERMATOLOGIC SURGERY, 2014, 40 (12) :1334-1339
[7]   The short-term effect of stabilization-type splints on the local asymmetry of masseter muscle sites [J].
Bertram, S ;
Rudisch, A ;
Bodner, G ;
Emshoff, R .
JOURNAL OF ORAL REHABILITATION, 2001, 28 (12) :1139-1143
[8]  
BORODIC GE, 1992, J CLIN NEURO-OPHTHAL, V12, P121
[9]   HISTOLOGIC ASSESSMENT OF DOSE-RELATED DIFFUSION AND MUSCLE-FIBER RESPONSE AFTER THERAPEUTIC BOTULINUM-A TOXIN INJECTIONS [J].
BORODIC, GE ;
FERRANTE, R ;
PEARCE, LB ;
SMITH, K .
MOVEMENT DISORDERS, 1994, 9 (01) :31-39
[10]   ULTRASTRUCTURAL-CHANGES IN THE MASSETER MUSCLE OF MACACA-FASCICULARIS RESULTING FROM INTRAMUSCULAR INJECTIONS OF BOTULINUM TOXIN TYPE-A [J].
CAPRA, NF ;
BERNANKE, JM ;
PORTER, JD .
ARCHIVES OF ORAL BIOLOGY, 1991, 36 (11) :827-836